ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

February 2, 2007

Advocacy. Bypass Budget Treated As Serious Funding Request By Advocates

January 30, 1998

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

May 21, 1999

In Brief: Clark, Hutchinson Gain New Honors; Nominations Open For Bristol-Myers Award; NIH Appointments

July 1, 1983

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995